BPA Call HHSN263201500079B-HHSN27100001
Ended Awarded
- Contract number
- HHSN27100001
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,160
Award facts
- Contract value 100% obligated
- $8,159.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V., by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The contract has a ceiling value of $8,159.50 and was awarded on September 12, 2016, with an ultimate completion date of April 30, 2017.
The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. Qiagen, LLC, a foreign-owned, for-profit manufacturer, is providing a range of molecular diagnostics products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, and bioinformatics software to support biomedical research, public health, and law enforcement programs across various government agencies. This contract was not set aside for any special designation.
Qiagen N.V., the parent company of Qiagen, LLC, holds several other significant federal Indefinite Delivery Vehicles (IDVs) across multiple agencies, such as a $2.5 million Indefinite Delivery Contract (IDC) with the FBI and a $6.5 million Blanket Purchase Agreement (BPA) with the Defense Health Agency, demonstrating the company's extensive experience and capabilities in delivering specialized molecular diagnostics products and services to the federal government.
Quick answers
Who was awarded contract HHSN27100001?
HHSN27100001 was awarded to Qiagen, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 12, 2016.
How much is contract HHSN27100001 worth?
The government has obligated $8,160 on HHSN27100001.
Is contract HHSN27100001 an order under another contract?
Yes. HHSN27100001 is a BPA call under HHSN263201500079B, a blanket purchase agreement.
Was contract HHSN27100001 competed?
The extent of competition for HHSN27100001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award